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Interoffice Memorandum 
SCHOOL OF PHARMACY 
OFFICE OF THE DEAN 
University, MS 38677 
Phone: (662) 915-7265 Fax: (662) 915-5704 
 
TO:  All School of Pharmacy and USDA Personnel 
 
FROM: Charles D. Hufford, Associate Dean for Research and Graduate Programs 
 
DATE: September 28, 2009 
 
SUBJECT: Research News (#2) 
 
 
The following GRANTS/CONTRACTS have recently been awarded: 
1. Dr. Mitchell Avery (P.I.-Medicinal Chemistry), and Dr. Stephen Cutler (Co-P.I.-
Medicinal Chemistry). Development and Testing of New Antimalarial Drugs - FY 
2009-2010 (Centers for Disease Control and Prevention), $200,000, August 8, 2008-
July 31, 2010. 
2. Dr. Benjamin Banahan (P.I.-Center for Pharmaceutical Marketing and 
Management/Research Institute for Pharmaceutical Sciences), Dr. Yi Yang (Co-P.I.-
Pharmacy Administration), Dr. Patrick Pace (Co-P.I.- Center for Pharmaceutical 
Marketing and Management/Research Institute for Pharmaceutical Sciences), Dr. 
John Bentley (Co-P.I.-Pharmacy Administration), and Dr. Donna West (Co-P.I.-
Pharmacy Administration). Using a Medicare Claims Data Repository to Evaluate 
Medication Utilization and Safety in the Elderly Population (Department of Health 
and Human Services/Health Resources and Services Administration), $235,620, 
September 1, 2009-August 31, 2011. 
3. Dr. Alice Clark (P.I.-National Center for Natural Products Research), and Dr. 
Ameeta Agarwal (Co-P.I.-National Center for Natural Products Research). New 
Drugs for Opportunistic Infections - FY 2009-2010 (National Institute of Allergy and 
Infectious Disease), $361,649, July 1, 2009-June 30, 2010. 
4. Dr. Stephen Cutler (P.I.-Medicinal Chemistry). Center for Research Excellence in 
Natural Products Neuroscience - Year 4 (National Center for Research Resources), 
$1,969,436, July 1, 2009-June 30, 2010. 
5. Dr. Stephen Cutler (P.I.-Medicinal Chemistry), and Dr. Susan Manly (Co-P.I.- 
National Center for Natural Products Research). Center for Research Excellence in 
Natural Products Neuroscience – Administrative Supplement (National Institutes of 
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Health/National Center for Research Resources), $584,617, September 14, 2009-
September 13, 2011. 
6. Dr. Robert Doerksen (P.I.-Medicinal Chemistry). Innovations through 
Computational Science-Bridge Funding (Mississippi State University/National 
Science Foundation), $13,491, June 9, 2009-July 31, 2009. 
7. Dr. Mark Hamann (P.I.-Pharmacognosy). The Isolation and Characterization of 
Antimalarial Agents with Marine Micro-Organisms - Year 4 (Medicines for Malaria 
Venture), $15,000, January 1, 2009-December 31, 2011. 
8. Dr. Raymond Highsmith (P.I.-National Institute for Undersea Science and 
Technology [NIUST]), Dr. Marc Slattery (Co-P.I.-Pharmacognosy), and Dr. Carol 
Lutken (Co-P.I.-MS Mineral Resources Institute). NIUST Tropical Ecosystem 
Science and Technology (U.S. Dept. of Commerce/National Oceanic and 
Atmospheric Administration), $849,000, October 1, 2009-September 30, 2010. 
9. Dr. Erin Holmes (P.I.-Pharmacy Administration). Electronic Health Records Market 
Assessment in Mississippi (Louisiana Health Care Review, Inc.), $15,000, July 1, 
2009-August 14, 2009. 
10. Dr. Ikhlas Khan (P.I.- National Center for Natural Products Research), and Dr. 
Larry Walker (Co-P.I.-National Center for Natural Products Research). Discovery 
and Development of Natural Product-Based Insect Management Compounds for 
Medical, Veterinary and Urban Concern - Amendment 2 (U.S. Department of 
Agriculture), $520,002, September 24, 2007-June 14, 2010. 
11. Dr. Ikhlas Khan (P.I.- National Center for Natural Products Research), and Dr. 
Larry Walker (Co-P.I.-National Center for Natural Products Research). Botanical 
Dietary Supplement Research (Food and Drug Administration), $1,608,000, 
September 20, 2009-August 31, 2010. 
12. Dr. Ikhlas Khan (P.I.- National Center for Natural Products Research). Science 
Based Authentication of Dietary Supplements (Food and Drug Administration), 
$552,000, July 1, 2009-June 30, 2010. 
13. Dr. David Murray (P.I.-Pharmacology). The Role of Protease Activated Receptor-2 
(PAR-2) and Cyclo-oxygenase-2 (Cox-2) in Ventricular Remodeling (American 
Heart Association), $132,000, July 1, 2009-June 30, 2011. 
14. Dr. S. Narasimha Murthy (P.I.-Pharmaceutics). Electropulsation Mediated Drug 
Therapy for Onychomycosis (National Institutes of Health), $69,830, August 1, 2009-
July 31, 2010. 
15. Dr. Dale Nagle (P.I.-Pharmacognosy), and Dr. Yu-Dong Zhou (Co-P.I.-
Pharmacognosy). Anticancer Drug Discovery that Targets Tumor Hypoxia - Year 5 
(National Institutes of Health/National Cancer Institute), $280,987, July 1, 2009-May 
31, 2010. 
16. Dr. Michael Repka (P.I.-Pharmaceutics), and Dr. Soumyajit Majumdar (Co-P.I.-
Pharmaceutics). Transmucosal Intra-Oral Drug Delivery Systems for THC - Year 2 
(ElSohly Laboratories, Inc./National Institutes of Health), $207,803, June 1, 2009-
May 31, 2010. 
17. Dr. John Rimoldi (P.I.-Medicinal Chemistry). Synthesis of HIV-1 Integrase 
Inhibitors (Panvirex, L.L.C.), $33,540, July 1, 2009-October 31, 2009. 
18. Dr. Leigh Ann Ross (P.I.-Pharmacy Practice). University of Mississippi Medical 
Center/University of Mississippi School of Pharmacy/Pharmacy Practice’s 
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Agreement - FY 2010-2014 (Department of Pediatrics), $117,875, July 1, 2009-June 
30, 2014. 
19. Dr. Leigh Ann Ross (P.I.-Pharmacy Practice). Delta Diabetes Project - FY 2008-
2009 (University of Mississippi Medical Center), $38,973, August 1, 2008-July 31, 
2009. 
20. Dr. Leigh Ann Ross (P.I.-Pharmacy Practice), and Dr. Barbara Wells (Co-P.I.- 
Dean’s Office). Delta Pharmacy Patient Care Management Project (Delta Health 
Alliance/Health Resources and Services Administration), $200,000 (revising budget 
from $800,000 for a total of $1,000,000), July 1, 2009-June 30, 2010. 
21. Dr. Leigh Ann Ross (P.I.-Pharmacy Practice). PGY1 Community Pharmacy 
Residency Program (Biggs Drug Store), $7,500, July 1, 2009-June 30, 2010. 
22. Dr. Leigh Ann Ross (P.I.-Pharmacy Practice). UM School of Pharmacy/Pharmacy 
Practice/University of Mississippi Medical Center/Department of Medicine/Division 
of Infectious Diseases Agreement - FY 2009-2014 (University of Mississippi Medical 
Center), $69,725, July 1, 2009-June 30, 2014. 
23. Dr. Leigh Ann Ross (P.I.-Pharmacy Practice). University of Mississippi School of 
Pharmacy and Baptist Memorial Hospital-North Mississippi Agreement - FY 2009-
2010 (Baptist Memorial Hospital-North Mississippi), $56,250, August 19, 2009-
August 18, 2010.  
24. Dr. Leigh Ann Ross (P.I.-Pharmacy Practice). University of Mississippi Medical 
Center/University of Mississippi School of Pharmacy/Dept. of Pharmacy Practice – 
Contract for Residency Program Support - FY 2009-2010 (University of Mississippi 
Medical Center), $25,000, July 1, 2009-June 30, 2010.  
25. Dr. James Sims (P.I.-Pharmacognosy). Biosynthetic Routes to Drug Development 
for AIDS Ol Mtb (National Institutes of Health/National Institute of Allergy and 
Infectious Diseases), $45,218, September 11, 2009-September 10, 2012. 
26. Dr. Robert Speth (P.I.-Pharmacology). Brain Specific Non-AT1, Non-AT2 
Angiotensin Binding Site (National Institutes of Health/National Heart, Lung and 
Blood Institute), $223,150, July 1, 2009-June 30, 2010. 
27. Dr. Babu Tekwani (P.I.-National Center for Natural Products Research), Dr. 
Muhammad Ilias (Co-P.I.-National Center for Natural Products Research), and Dr. 
Dhammika Nanayakkara (Co-P.I.-National Center for Natural Products Research). 
Natural Product Leads for New Drug Discovery Against Leishmaniasis (U.S. Army 
Medical Research Acquisition Activity), $1,132,768, August 1, 2009-August 31, 
2012. 
28. Dr. Gregory Tschumper, Dr. Amal Dass, Dr. Nathan Hammer, Dr. Keith Hollis, Dr. 
Randy Wadkins (P.I’s-Chemistry and Biochemistry), Dr. Yixin Chen (P.I.-Computer 
and Information Science), Dr. Robert Doerksen (P.I.-Medicinal Chemistry), and Dr. 
Maxine Harper (P.I.-Center for Educational Research and Evaluation). Modeling and 
Simulation of Complex Systems (Mississippi State University/National Science 
Foundation), $792,655, September 1, 2009-August 31, 2010. 
29. Dr. Larry Walker (P.I.-National Center for Natural Products Research). 
Development of Natural Products from Plants and Microbes for Replacement of 
Synthetic Pesticides - Amendment 5 (U.S. Department of Agriculture/Agricultural 
Research Service), $2,380,393, September 6, 2006-July 31, 2011.  
 4 
30. Dr. Barbara Wells (P.I.- Dean’s Office), and Dr. Charles Hufford (Co-P.I.- Dean’s 
Office). National Center for Natural Products Research – Phase II (Department of 
Health and Human Services/Health Resources and Services Administration), 
$941,490, September 1, 2008-September 30, 2013. 
31. Dr. Barbara Wells (P.I.- Dean’s Office), and Dr. Leigh Ann Ross (Co-P.I.- 
Pharmacy Practice). UM School of Pharmacy Instructional and Research Facility – 
Year 2 (Department of Health and Human Services/Health Resources and Services 
Administration), $5,651,910, September 1, 2008-September 30, 2011. 
32. Dr. Donna West-Strum (P.I.-Pharmacy Administration), and Dr. John Bentley (Co-
P.I.-Pharmacy Administration). Baseline Evaluation of Science of Safety at U.S. 
Colleges of Pharmacy (Virginia Commonwealth University/American Association of 
Colleges of Pharmacy), $21,000, January 1, 2009-September 30, 2009. 
33. Dr. Kristine Willett (P.I.-Pharmacology). Research Experience Opportunity 
Program: Summer Research Opportunities for Undergraduates (Mississippi 
Functional Genomics Network/National Institutes of Health), $1,000, May 14, 2009-
August 15, 2009. 
34. Dr. Kristine Willett (P.I.-Pharmacology/Environmental Toxicology Research 
Program). Fish Gill Toxicity (U.S. Army, Engineering Research and Development 
Center), $2,500, July 1, 2009-September 30, 2009. 
35. Dr. Kristine Willett (P.I.-Pharmacology), and Dr. Marc Slattery (Co-P.I.-
Pharmacognosy). YES Analysis of Cruise Ship Effluent (Florida-Spectrum 
Environmental Services, Inc.), $2,400, March 1, 2009-September 30, 2009. 
36. Dr. Kristine Willett (P.I.-Pharmacology), and Dr. Marc Slattery (Co-P.I.-
Pharmacognosy). YES Analysis of Cruise Ship Effluent (SGS North America, Inc.), 
$4,500, February 1, 2009-August 31, 2009. 
37. Dr. Kristine Willett (P.I.-Pharmacology). Roles of CYP1 & 19 in Fundulus Steroids 
& PAH Metabolism-Administrative Supplement (National Institutes of 
Health/National Institute of Environmental Health Sciences), $86,219, September 6, 
2009-August 31, 2010. 
38. Dr. Jordan Zjawiony (P.I.-Pharmacognosy), and Dr. Charles Burandt (Co-P.I.-
National Center for Natural Products Research). Chemistry and Pharmacology of 
Newly Emerging Psychoactive Plants (National Institutes of Health), $71,584, May 1, 
2009-April 30, 2011. 
 
The following PUBLICATIONS have appeared: 
1. S.A. Ahmed, S.I. Khalifa, and Mark Hamann, “Antiepileptic Ceramides from the 
Red Sea Sponge Negombata corticata”, Journal of Natural Products, 71, 513-515 
(2008). 
2. Sai Prasad Boddu, M.R. Yamsani, S. Potharaju, S. Veeraraghavan, S. Rajak, S. 
Kumar, Bonnie Avery, Michael Repka, and K. Varanasi, “Influence of grapefruit 
juice on the pharmacokinetics of diltiazem in Wistar rats upon single and multiple 
dosage regimens”, Pharmazie, 64, 525-531 (2009). 
3. E.A. Bourassa, A.F. Sved, and Robert Speth, “Angiotensin modulation of rostral 
ventrolateral medulla (RVLM) in cardiovascular regulation”, Molecular and Cellular 
Endocrinology, 302, 167-175 (2009). 
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4. John Bowling, H.K. Pennaka, K. Ivey, S. Wahyuono, M. Kelly, R.F Schinazi, F.A. 
Valeriote, D.E. Graves, and Mark Hamann, “Antiviral and Anticancer Optimization 
Studies of the DNA-binding Marine Natural Product Aaptamine”, Chem Biol Drug 
Des, 71, 205-215 (2008).  
5. P. Carvalho, L.M. Kutrzeba, Jordan Zjawiony, and Mitchell Avery, 
“(2S,4aR,6aR,7R,9S,10aS,10bR)-7-Carboxy-2-(3-furyl)-6a,10b-dimethyl-4,10-
dioxoperhydrobenzo[f]isochromen-9-yl acetate”, Acta Crystallographica, 65, 471-
472 (2009). 
6. Suman Chandra, Hemant Lata, Ikhlas Khan and Mahmoud ElSohly, 
“Photosynthetic response of Cannabis sativa L. to variations in photosynthetic photon 
flux densities, temperature and CO2 conditions”, Physiology and Molecular Biology 
of Plants, 14, 299-306 (2008). 
7. Pankaj Daga, and Robert Doerksen, “Stereoelectronic Properties of 
Spiroquinazolinones in Differential PDE7 Inhibitory Activity”, Journal of 
Computational Chemistry, 29, 1945-1954 (2008). 
8. J.A. Diers, K.D. Ivey, Abir El-Alfy, J. Shaikh, J. Wang, Anna Kochanowska, J.F. 
Stoker, Mark Hamann, and R.R. Matsumoto, “Identification of antidepressant drug 
leads through the evaluation of marine natural products with neuropsychiatric 
pharmacophores”, Pharmacology, Biochemistry and Behavior, 89, 46-53 (2008). 
9. Yuanqing Ding, Xing-Cong Li, and Daneel Ferreira, “Theoretical Calculation of 
Electronic Circular Dichroism of a Hexahydroxydiphenoyl-Containing Flavanone 
Glycoside”, J. Nat. Prod., 72, 327-335 (2009). 
10. M.S. Donia, Bin Wang, D.C. Dunbar, P.V. Desai, A. Patny, Mitchell Avery, and 
Mark Hamann, “Mollamides B and C, Cyclic Hexapeptides from the Indonesian 
Tunicate Didemnum molle”, Journal of Natural Products, 71, 941-945 (2008). 
11. Nurdan Duzgoren-Aydin, “Health Effects of Atmospheric Particulates: A Medical 
Geology Perspective”, Journal of Environmental Science and Health, Part C, 26, 1-
39 (2008). 
12. Nurdan Duzgoren-Aydin, and A.L. Weiss, “Use and abuse of Pb-isotope 
fingerprinting technique and GIS mapping data to assess lead in environmental 
studies”, Environmental Geochemistry and Health, 30, 577-588 (2008). 
13. Nurdan Duzgoren-Aydin, and A. Aydin, “Distribution of rare earth elements and 
oxyhydroxide phases within a weathered felsic igneous profile in Hong Kong”, 
Journal of Asian Earth Sciences, 34, 1-9 (2009). 
14. Ashley Ellis, “OTC product: RESPeRATE blood pressure-lowering device”, 
Pharmacy Today, 16 (August 2009). 
15. K.A. ElSayed, A.A. Khalil, M. Yousaf, Guillermo Labadie, G.M. Kumar, S.G. 
Franzblau, A.M.S. Mayer, Mitchell Avery, and Mark Hamann, “Semisynthetic 
Studies on the Manzamine Alkaloids”, J. Nat. Prod., 71, 300-308 (2008). 
16. H. Fan, Jiangnan Peng, Mark Hamann, and J.F. Hu, “Lamellarins and Related 
Pyrrole-Derived Alkaloids from Marine Organisms”, Chem. Rev., 108, 264-287 
(2008). 
17. Ahmed Galal, Waseem Gul, Desmond Slade, Samir Ross, S. Feng, M.G. 
Hollingshead, M.C. Alley, G. Kaur, and Mahmoud ElSohly, “Synthesis and 
evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing 
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anticancer and antiprotozoal activity”, Bioorganic & Medicinal Chemistry, 17, 741-
751 (2009). 
18. T. Grkovic, Yuanqing Ding, Xing-Cong Li, V.L. Webb, Daneel Ferreira, and B.R. 
Copp, “Enantiomeric Discorhabdin Alkaloids and Establishment of Their Absolute 
Configurations Using Theoretical Calculations of Electronic Circular Dichroism 
Spectra”, J. Org. Chem., 73, 9133-9136 (2008). 
19. Mohamed Ibrahim, A.G. Shilabin. S. Prasanna, Melissa Jacob, Shabana Khan, 
Robert Doerksen, and Mark Hamann, “2-N-Methyl modifications and SAR studies 
of manzamine A”, Bioorganic & Medicinal Chemistry, 16, 6702-6706 (2008). 
20. Haidy Kamel, Y.B. Kim, John Rimoldi, F.R. Fronczek, Daneel Ferreira, and Marc 
Slattery, “Scalarane Sesterterpenoids: Semisynthesis and Biological Activity”, J. 
Nat. Prod., 72, 1492-1496 (2009). 
21. V.T. Karamyan, Rama Gadepalli, John Rimoldi, and Robert Speth, “Brain AT1 
Angiotensin Receptor Subtype Binding: Importance of Peptidase Inhibition for 
Identification of Angiotensin II as Its Endogenous Ligand”, The Journal of 
Pharmacology and Experimental Therapeutics, 331, 170-177 (2009). 
22. Dion Kevin, Damaris Meujo, and Mark Hamann, “Polyether ionophores: broad-
spectrum and promising biologically active molecules for the control of drug-resistant 
bacteria and parasites”, Expert Opinion on Drug Discovery, 4, 109-146 (2009). 
23. Jin-Ki Kim, J. Anderson, H. Jun, Michael Repka, and Seongbong Jo, “Self-
assembling peptide amphiphile-based nanofiber gel for bioresponsive cisplatin 
delivery”, Mol Pharm, 6, 978-985 (2009). 
24. Anna Kochanowska, K.V. Rao, S. Childress, Abir El-Alfy, R.R. Matsumoto, M. 
Kelly, G.S. Stewart, K.J. Sufka, and Mark Hamann, “Secondary Metabolites from 
Three Florida Sponges with Antidepressant Activity”, J. Nat. Prod., 71, 186-189 
(2008). 
25. L.M. Kutrzeba, Daneel Ferreira, and Jordan Zjawiony, “Salvinorins J from Salvia 
divinorum: Mutarotation in the Neoclerodane System”, J. Nat. Prod., 72, 1361-1363 
(2009). 
26. J.S. Kwon, I.K. Park, A.S. Cho, S.M. Shin, M.H. Hong, S.Y. Jeong, Y.S. Kim, J.J. 
Min,, M.H. Jeong, W.J. Kim, Seongbong Jo, S.H. Pun, J.G. Cho, J.C. Park, J.C. 
Kang, and Y. Ahn, “Enhanced angiogenesis mediated by vascular endothelial growth 
factor plasmid-loaded thermo-responsive amphiphilic polymer in a  rat myocardial 
infarction model”, Journal of Controlled Release, 138, 168-176 (2009). 
27. Hemant Lata, Suman Chandra, Ikhlas Khan and Mahmoud ElSohly, 
“Thidiazuron induced high frequency direct shoot organogenesis of Cannabis sativa 
L”, In Vitro Cellular and Developmental Biology-Plant, 45, 12-19 (2009). 
28. Hemant Lata, Suman Chandra, Ikhlas Khan and Mahmoud ElSohly, 
“Propagation through Alginate Encapsulation of Axillary Buds of Cannabis sativa L 
– An Important Medicinal Plant” Physiology and Molecular Biology of Plants, 15, 
79-86 (2009). 
29. Hemant Lata, Suman Chandra, Natascha Techen, Ikhlas Khan and Mahmoud 
ElSohly, “Assessment of the Genetic Stability of Micropropagated Plants of 
Cannabis sativa by ISSR Markers”, Planta Medica, 75, 1-4 (2009). 
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30. Hemant Lata, Cassia Mizuno, and Rita Moraes, “The role of biotechnology in the 
production of the anticancer compound Podophyllotoxin”, Methods in Molecular 
Biology, 547, 387-402 (2009). 
31. Francisco León, Eman Habib, Jessica Adkins, Edward Furr, Christopher 
McCurdy, and Stephen Cutler, “Phytochemical Characterization of the Leaves of 
Mitragyna speciosa Grown in USA”, Natural Products Communications, 4, 907-910 
(2009). 
32. A.O.W. Leung, Nurdan Duzgoren-Aydin, K.C. Cheung, and M.H. Wong, “Heavy 
Metals Concentrations of Surface Dust from e-Waste Recycling and Its Human 
Health Implications in Southeast China”, Environ. Sci. Technol., 42, 2674-2680 
(2008). 
33. Vamsi Madgula, Bharathi Avula, R.S. Pawar. Y.J. Shukla, Ikhlas Khan, Larry 
Walker, and Shabana Khan, “Characterization of in Vitro Pharmacokinetic 
Properties of Hoodigogenin A from Hoodia gordonii”, Planta Med, 75, 1-8 (2009). 
34. Vamsi Madgula, Zulfiqar Ali, Troy Smillie, Ikhlas Khan, Larry Walker, and 
Shabana Khan, “Alkaloids and Saponins as Cytochrome P450 Inhibitors from Blue 
Cohosh (Caulophyllum thalictroides) in an in vitro Assay”, Planta Med, 75, 329-332 
(2009). 
35. Soumyajit Majumdar, Ketan Hippalgaonkar, and Ramesh Srirangam, “Vitreal 
Kinetics of Quinidine in Rabbits in the Presence of Topically Coadministered P-
Glycoprotein Substrates/Modulators”, Drug Metabolism and Disposition, 37, 1718-
1722 (2009). 
36. A.M.S. Mayer, A.D. Rodríguez, R.G.S. Berlinck, and Mark Hamann, “Marine 
pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, 
anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, 
antituberculosis, and antiviral activities; affecting the cardiovascular, immune and 
nervous systems, and other miscellaneous mechanisms of action”, Biochimica et 
Biophysica Acta, 283-308 (2009). 
37. M. Mendoza, D. Mills, Hemant Lata, Suman Chandra, Mahmoud ElSohly, and J. 
Almiral, “Genetic Individualization of Cannabis sativa by an STR Multiplex”, 
Analytical and Bioanalytical Chemistry, 393, 719-726 (2009). 
38. N.M. Mohamed, V. Rao, Mark Hamann, M. Kelly, and R.T. Hill, “Monitoring 
Bacterial Diversity of the Marine Sponge Ircinia strobilina upon Transfer into 
Aquaculture”, Applied and Environmental Microbiology, 4133-4143 (2008). 
39. M.K. Na, Damaris Meujo, Dion Kevin, Mark Hamann, M. Anderson, and R.T. 
Hill, “A new antimalarial polyether from a marine Streptomyces sp. H668”, 
Tetrahedron Letters, 49, 6282-6285 (2008). 
40. Dale Nagle, and Yu-Dong Zhou, “Marine natural products as inhibitors of hypoxic 
signaling in tumors”, Phytochem Rev, 8, 415-529 (2009). 
41. R. Namgung, S. Nam, S.K. Kim, S. Son, K. Singha, J.S. Swon, Y. Ahn, M.H. Jeong, 
I.K. Park, Vivekkumar Garripelli, and Sengbong Jo, “An acid-labile temperature-
responsive sol-gel reversible polymer for enhanced gene delivery to the myocardium 
and skeletal muscle cells”, Biomaterials, 30, 5225-5233 (2009). 
42. S. Prasanna, and Robert Doerksen, “Topological Polar Surface Area: A Useful 
Descriptor in 2D-QSAR”, Current Medicinal Chemistry, 16, 431-448 (2009). 
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43. S. Prasanna, Pankaj Daga, A. Xie, and Robert Doerksen, “Glycogen synthase 
kinase-3 inhibition by 3-anilino-4-phenylmaleimides: insights from 3-D-QSAR and 
docking”, J Comput Aided Mol Des, 23, 113-127 (2009). 
44. Mohamed Radwan, Mahmoud ElSohly, Desmond Slade, S.A. Ahmed, Ikhlas 
Khan, and Samir Ross, “Biologically Active Cannabinoids from High-Potency 
Cannabis sativa”, J. Nat. Prod., 72, 906-911 (2009). 
45. K.V. Rao, M.K. Na, J.C. Cook, Jiangnan Peng, R. Matsumoto, and Mark Hamann, 
“Kahalalides V-Y Isolated from a Hawaiian Collection of the Sacoglossan Mollusk 
Elysia rufescens”, Journal of Natural Products, 71, 772-778 (2008). 
46. Daniel Riche, Wes Pierce, and Travis King, “Vitamin D and Cardiovascular 
Disease: A Second Look”, Pharmacotherapy, 29, 177-179 (September 2009). 
47. Daniel Riche, H.E. East, and K.D. Riche, “Impact of sitagliptin on markers of beta-
cell function: a meta-analysis”, Am J Med Sci, 337, 321-328 (May 2009). 
48. Daniel Riche, Deborah Minor, Amber Holdiness and H.E. East, “An issue of 
dependence: implications from the Aliskiren in the Evaluation of Proteinuria in 
Diabetes (AVOID) trial”, J Clin Hypertens (Greenwich), 11, 89-93 (February 2009). 
49. Samir Ross, R. Rodríguez-Guzmán, Mohamed Radwan, Melissa Jacob, Yuanqing 
Ding, Xing-Cong Li, Daneel Ferreira, and Susan Manly, “Sorocenols G and H, 
Anti-MRSA Oxygen Heterocyclic Diels-Alder-Type Adducts from Sorocea 
muriculata Roots”, J. Nat. Prod., 71, 1764-1767 (2008). 
50. Volodymyr Samoylenko, Melissa Jacob, Shabana Khan, Jianping Zhao, Babu 
Tekwani, J.O. Midiwo, Larry Walker, and Ilias Muhammad, “Antimicrobial, 
Antiparasitic and Cytotoxic Spermine Alkaloids from Albizia schimperiana”, Natural 
Product Communications, 4, 791-796 (2009). 
51. A.G. Shilabin, N. Kasanah, Babu Tekwani, and Mark Hamann, “Kinetic Studies 
and Bioactivity of Potential Manzamine Prodrugs”, Journal of Natural Products, 71, 
1218-1221 (2008). 
52. A.T. Slominski, M.A. Zmijewski, I. Semak, T. Sweatman, Z. Janjetovic, W. Li, 
Jordan Zjawiony, and R.C. Tuckey, “Sequential Metabolism of 7-
Dehydrocholesterol to Steroidal 5,7-Dienes in Adrenal Glands and Its Biological 
Implication in the Skin”, PLoS ONE, 4 (February 2009). 
53. Robert Speth, “Tribute – A life well-lived: Henry I. ‘Hank’ Yamamura”, Life 
Sciences, 84, 634-636 (2009). 
54. R. Stanikunaite, Mohamed Radwan, J.M. Trappe, F. Fronczek, and Samir Ross, 
“Lanostane-Type Triterpenes from the Mushroom Astraeus pteridis with 
Antituberculosis Activity”, Journal of Natural Products, 71, 2077-2079 (2008). 
55. R. Stanikunaite, Shabana Khan, J.M. Trappe, and Samir Ross, “Cyclooxygenase-2 
Inhibitory and Antioxidant Compounds from the Truffle Elaphomyces granulatus”, 
Phytotherapy Research, 23, 575-578 (2009). 
56. I.I. Tatli, F. Kong, X. Feng, G. Carter, K.V. Rao, and Mark Hamann, “7-Methyl-9-
oxo-dec-7-eneoic acid from the Red Sea sponge Ircinia sp”, Journal of Chemical 
Research, 50-51 (2008). 
57. Barbara Wells, J.T. DiPiro, T.L. Schwinghammer, and C. DiPiro, Pharmacotherapy 
Handbook, 7th ed. McGraw-Hill, New York, New York (2009). 
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58. A. Xie, S. Odde, S. Prasanna, and Robert Doerksen, “Imidazole-containing 
farnesyltransferase inhibitors: 3D quantitative structure-activity relationship and 
molecular docking”, J Comput Aided Mol Des, 23, 431-448 (2009). 
59. W.H. Xu, Melissa Jacob, Ameeta Agarwal, Alice Clark, Z.S. Liang, and Xing-
Cong Li, “Verbesinosides A-F, 15,27-Cyclooleanane Saponins from the American 
Native Plant Verbesina virginica”, J. Nat. Prod., 72, 1022-1027 (2009). 
60. F. Yan, R.V. Bikbulatov, V. Mocanu, N. Dicheva, C.E. Parker, W.C. Wetsel, P.D. 
Mosier, R.B. Westkaemper, J.A. Allen, Jordan Zjawiony, and B.L. Roth, “Structure-
Based Design, Synthesis, and Biochemical and Pharmacological Characterization of 
Novel Salvinorin A Analogues as Active State Probes of the κ-Opioid Receptor”, 
Biochemistry, 48, 6898-6908 (2009). 
61. Jordan Zjawiony, “Antimicrobial and Antiviral Metabolites from Polypore Fungi”, 
Novel Therapeutic Agents from Plants”, 36-59 (2009). 
62. M.A. Zmijewski, W. Li, Jordan Zjawiony, T.W. Sweatman, J. Chen, D.D. Miller, 
and A.T. Slominski, “Photo-conversion of two epimers (20R and 20S) of pregna-5,7-
diene-3β, 17α, 20-triol and their bioactivity in melanoma cells”, Steroids, 74, 218-
228 (2009). 
 
TECHNOLOGY TRANSFER transactions: 
(In the interest of protecting confidential information, the names and titles associated 
with School of Pharmacy invention disclosures and patent applications will no longer be 
published until after a patent has issued.) 
Research Disclosures Filed in 2009: 1 
US Patents Pending: 29 
Recent US Patents Granted: none 
 
The following SPECIAL ANNOUNCEMENTS are also listed: 
• Pharmacy Administration faculty selected: Suvapun Bunniran as the recipient of 
the 2009-2010 Outstanding Student Research Paper Award; and Kyle Null as the 
recipient of the 2009-2010 William E. Farlow Fellowship Award. 
• Dr. S. Narasimha Murthy received a Global Indus Technovators Award from 
MIT’s IBC for his ongoing study of electrically mediated, non-invasive 
technologies for drug delivery, diagnosis and treatment of various diseases.  Dr. 
Murthy has developed several technologies to rapidly infuse pharmaceuticals 
across the skin and into the body. 
• Dr. Michael Repka was an Invited Speaker at a workshop sponsored by Thermo 
Fisher Scientific, June 3-4, 2009, at Amgen, Thousand Oaks, CA.  His topic was 
“Hot-Melt Extrusion of Polymer Blends and Sensitive Actives”. 
• Dr. John Rimoldi has been awarded the Chemists Travel Assistance Award by 
the Society of Environmental Toxicology and Chemistry (SETAC).  The award 
will cover registration fees and lodging expenses for Dr. Rimoldi to attend the 
SETAC North America 30th Annual Meeting, set for November 19-23 in New 
Orleans.  The award will also provide for up to three graduate students to attend 
the meeting at a reduced cost. 
• Dr. Samir Ross was presented with the School of Pharmacy Researcher of the 
Year Award during the Faculty Retreat in August. 
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• The article, “Biologically Active Cannabinoids from High-Potency Cannabis 
sativa” - Mohamed Radwan, Mahmoud ElSohly, Desmond Slade, S.A. 
Ahmed, Ikhlas Khan, and Samir Ross - was one of the Ten Most-Accessed 
Articles from the Journal of Natural Products during April-June 2009. 
• Amir Wahba was the recipient of the Robert A. Magarian Student Podium 
Presentation Award at the 2009 Medicinal Chemistry/Pharmacognosy MALTO 
Meeting. 
• Recent Poster/Podium Presentations: 
(a) Sunil Battu, Z. Rahman, Soumyajit Majumdar, Waseem Gul, Mahmoud 
ElSohly, and Michael Repka, “Evaluation of a Novel ∆9-
Tetrahydrocannabinol Prodrug, ELI-UNI-88-4”, Annual Neuroscience and 
Behavior Research Day, The University of Mississippi School of Medicine, 
Jackson, MS, 2008 (Poster). 
(b) Sunil Battu, Z. Rahman, Soumyajit Majumdar, Waseem Gul, Mahmoud 
ElSohly, and Michael Repka, “Physico-Chemical Characterization of a 
Novel ∆9-Tetrahydrocannabinol Prodrug, ∆9-The Valinate, Southern Regional 
Discussion Group”, PharmForum, The University of Mississippi, Oxford, 
MS, May 2009 (Podium). 
(c) Sunil Battu, Noorullah Mohammed, Weibin Deng, and Michael Repka, 
“Influence of Extruder Type on Content Uniformity and Effect of a 
Processing Aid on Drug Release of Hot-Melt Extruded Polyethylene Oxide 
Films, PharmForum, The University of Mississippi, Oxford, MS, May 2009 
(Poster). 
(d) Weibin Deng, Abhilasha Singh, Sunil Battu, Noorullah Mohammed, 
Seongbong Jo, and Michael Repka, “Bioadhesive Properties of Hot-Melt 
Extruded Films Containing Lidocaine HC1, Metformin HC1 and 
Prochlorperazine Maleate”, PharmForum, The University of Mississippi, 
Oxford, MS, May 2009 (Poster). 
(e) Jiannan Lu, J. Zhou, and Michael Repka, “Preparation and Characterization 
of Bovine Serum Albumin-loaded Chitosan Self-assembled Nanomicelles, 
PharmForum, The University of Mississippi, Oxford, MS, May 2009 (Poster). 
(f) Abhilasha Singh, Weibin Deng, Sunil Battu, Noorullah Mohammed, 
Seongbong Jo, and Michael Repka, “Influence of Drug and Drug Load on 
the Mechanical Properties of Hot-Melt Extruded Polyethylene Oxide Films”, 
PharmForum, The University of Mississippi, Oxford, MS, May 2009 (Poster). 
 
Please continue to send me important research and graduate information so that I might 
share it with your faculty colleagues.   
 
This information is now being posted on the School of Pharmacy web page 
(www.pharmacy.olemiss.edu).   
 
